IRIS
BARONE, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.254
AS - Asia 2.234
EU - Europa 1.554
SA - Sud America 328
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 46
Totale 6.478
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.162
SG - Singapore 1.023
RU - Federazione Russa 764
VN - Vietnam 422
CN - Cina 416
BR - Brasile 266
HK - Hong Kong 170
DE - Germania 141
FI - Finlandia 112
IT - Italia 109
FR - Francia 88
NL - Olanda 77
IE - Irlanda 65
UA - Ucraina 61
GB - Regno Unito 54
CA - Canada 47
SE - Svezia 38
IN - India 31
MX - Messico 31
AR - Argentina 26
JP - Giappone 23
IQ - Iraq 18
PH - Filippine 18
ZA - Sudafrica 17
BD - Bangladesh 16
ES - Italia 14
TR - Turchia 14
ID - Indonesia 13
CI - Costa d'Avorio 12
TH - Thailandia 11
PL - Polonia 10
EC - Ecuador 9
PK - Pakistan 8
CO - Colombia 7
JO - Giordania 7
VE - Venezuela 7
DZ - Algeria 5
IL - Israele 5
MA - Marocco 5
UZ - Uzbekistan 5
CL - Cile 4
EG - Egitto 4
EU - Europa 4
KR - Corea 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
KE - Kenya 3
KZ - Kazakistan 3
MD - Moldavia 3
SA - Arabia Saudita 3
TN - Tunisia 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GM - Gambi 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
SI - Slovenia 2
SN - Senegal 2
TL - Timor Orientale 2
YE - Yemen 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
CM - Camerun 1
CU - Cuba 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 6.434
Salva come PNG Salva come JPEG
Città #
Singapore 455
San Jose 269
Moscow 178
Chandler 170
Ashburn 160
Santa Clara 160
Hong Kong 151
Beijing 132
Ho Chi Minh City 125
Jacksonville 100
Hanoi 93
Los Angeles 83
Millbury 73
Amsterdam 70
Princeton 70
The Dalles 63
Lauterbourg 60
Nanjing 60
Munich 47
Boston 45
Dallas 35
Buffalo 31
New York 30
Wilmington 30
Nanchang 29
Seattle 26
São Paulo 25
Helsinki 22
Turku 21
Ottawa 20
Da Nang 19
Frankfurt am Main 19
Redondo Beach 19
Houston 17
Tokyo 17
Mexico City 16
Naples 16
Council Bluffs 15
Norwalk 15
Rome 15
Washington 15
Atlanta 14
Haiphong 13
Brooklyn 12
Columbus 12
Boardman 11
Ankara 10
Baghdad 10
Chicago 10
Denver 10
Kunming 10
Montreal 10
Stockholm 10
Belo Horizonte 9
Falkenstein 9
London 9
Napoli 9
Orem 9
Shanghai 9
Pune 8
Brasília 7
Chennai 7
Falls Church 7
Hải Dương 7
Jiaxing 7
Shenyang 7
Thái Bình 7
Tianjin 7
Miami 6
San Francisco 6
Toronto 6
Amman 5
Biên Hòa 5
Can Tho 5
Dublin 5
Hangzhou 5
Manchester 5
Philadelphia 5
Phoenix 5
Poplar 5
Rio de Janeiro 5
Tashkent 5
Bexley 4
Buon Ma Thuot 4
Catania 4
Changsha 4
Hebei 4
Hefei 4
Karachi 4
Kronberg 4
Las Vegas 4
Montevideo 4
Nuremberg 4
Porto Alegre 4
Santo André 4
Secaucus 4
Tampa 4
Vinh 4
Warsaw 4
Ann Arbor 3
Totale 3.410
Salva come PNG Salva come JPEG
Nome #
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. 165
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 155
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 153
Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial 142
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 140
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 140
Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients 130
Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. 123
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 121
Freezing of gait and executive functions in patients with Parkinson's disease. 121
Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. 120
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2. 116
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. 115
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. 112
No evidence of association between CAG expansions and essential tremor in a large cohort of italian patients 111
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. 111
RNA analysis of consensus sequence splicing mutations: implications for the diagnosis of Wilson disease. 108
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms 105
Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease. 105
Nitric oxide-hemoglobin interaction: a new biochemical hypothesis for signal changes in fMRI 105
Is arginine test a reliable tool for differential diagnosis of multiple system atrophy? 103
Dopamine agonist-based strategies in the treatment of Parkinson's disease. 102
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study. 101
Perspectives on recent advances in the understanding and treatment of Parkinson's disease. 98
Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients. 96
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. 96
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 96
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 96
Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia. 94
The PRIAMO study: background, methods and recruitment. 92
HOMER1 promoter analysis in Parkinson's disease: association study with psychotic symptoms. 92
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. 91
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test 90
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT. 90
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. 90
Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. 89
Linkage exclusion in Italian families with hereditary essential tremor. 88
Depression rating scales in Parkinson's disease: critique and recommendations. 87
HOMER1 promoter analysis in parkinson's disease: association study with psychotic symptoms 87
Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6-nitrodopamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration 83
Clinical and neurological abnormalities in adult celiac disease. 83
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. 82
Dopa-responsive pseudo-orthostatic tremor in parkinsonism. 81
Dopamine receptor agonists and depression in Parkinson's disease. 80
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. 78
Dopamine mediated responses in 6-OH-DA lesioned rats involve changes of the signal transduction. 77
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 77
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes. 76
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. 76
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. 75
Red flags for multiple system atrophy. 75
No evidence of association between CAG expansions and essential tremor in a large cohort of italian patients 74
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. 74
The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. 74
Pergolide monotherapy in the treatment of early PD. A randomized, controlled study. 73
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor features. 72
Amitriptyline as a prophylactic for migraine in children. 71
Behavioural sensitization in 6-OHDA lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB-related and JunD-related proteins 70
The status of dopamine nerve terminals in Parkinson\'s disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. 69
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 66
Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease. 65
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. 65
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 64
Headache in children, an epidemiological study. 63
Neurotransmission in Parkinson's disease: beyond dopamine. 63
Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. 63
The FRAGAMP study: environmental and genetic factors inParkinson's disease, methods and clinical features. 61
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). 58
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. 54
Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa. 48
null 12
Totale 6.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022316 0 0 0 4 0 9 1 12 67 12 52 159
2022/2023410 73 35 17 25 46 33 0 38 57 66 16 4
2023/2024321 7 38 32 35 27 53 2 32 0 10 73 12
2024/20251.726 101 82 6 9 86 133 174 118 71 170 638 138
2025/20263.059 348 196 306 293 607 109 392 157 382 192 40 37
2026/202749 34 15 0 0 0 0 0 0 0 0 0 0
Totale 6.478